15 Facts About Sun Pharmaceuticals


Sun Pharmaceuticals Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries across the globe.

FactSnippet No. 1,484,707

Sun Pharmaceuticals was founded by Dilip Shanghvi in 1983 in Vapi, Gujarat, with five products to treat psychiatry ailments.

FactSnippet No. 1,484,708

Sun Pharmaceuticals Pharma was listed on the stock exchange in 1994 in an issue oversubscribed 55 times.

FactSnippet No. 1,484,709

Sun Pharmaceuticals Pharma has complemented growth with select acquisitions over the last two decades.

FactSnippet No. 1,484,710

In 1996, Sun purchased a bulk drug manufacturing plant at Ahmednagar from Knoll Pharmaceuticals and MJ Pharma's dosage plant at Halol that are both U S FDA approved today.

FactSnippet No. 1,484,711

In 1997, Sun Pharma acquired Tamil Nadu Dadha Pharmaceuticals Limited based in Chennai, mainly for their extensive gynaecology and oncology brands.

FactSnippet No. 1,484,712

Also in 1997, Sun Pharma initiated their first foray into the lucrative US market with the acquisition of Caraco Pharmaceuticals, based in Detroit.

FactSnippet No. 1,484,713

In 1998, Sun Pharmaceuticals acquired a number of respiratory brands from Natco Pharma.

FactSnippet No. 1,484,714

In 2011, Sun Pharmaceuticals Pharma entered into a joint venture with MSD to bring complex or differentiated generics to emerging markets .

FactSnippet No. 1,484,715

On 6 April 2014, Sun Pharmaceuticals Pharma acquired Ranbaxy in a US$4 billion landmark transaction to create the world's 5th largest specialty generic pharmaceutical company.

FactSnippet No. 1,484,716

In March 2015, Sun Pharmaceuticals Pharma announced it had agreed to buy GlaxoSmithKline's opiates business in Australia to strengthen its pain management portfolio.

FactSnippet No. 1,484,717

From 2016 to 2018, Sun Pharmaceuticals Pharma launched some of its new products in the USA.

FactSnippet No. 1,484,718

In 2019, Sun Pharmaceuticals Pharma acquired Pola Pharma in Japan to strengthen its global dermatology presence.

FactSnippet No. 1,484,719

Sun Pharmaceuticals entered the Greater China market by partnering with China Medical System Holdings as well as launched a speciality product, Cequa, in the United States for the treatment of dry eyes.

FactSnippet No. 1,484,720

Sun Pharmaceuticals Pharma stood second in the India's Most Reputed Brands list in a study conducted by BlueBytes, a leading Media Analytics firm in association with TRA Research, a brand insights organization .

FactSnippet No. 1,484,721